Wilson, B., Viau, R., Perez, F., Jiang, H., Fowler, V. G., Chambers, H. F., . . . Evans, S. R. (2019). Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia. Open Forum Infect Dis.

Wilson, Brigid, Roberto Viau, Federico Perez, Hongyu Jiang, Vance G. Fowler, Henry F. Chambers, Barry N. Kreiswirth, Robert A. Bonomo, e Scott R. Evans. "Corrigendum To: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided By Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused By Escherichia Coli and Klebsiella Pneumonia." Open Forum Infect Dis 2019.

Wilson, Brigid, et al. "Corrigendum To: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided By Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused By Escherichia Coli and Klebsiella Pneumonia." Open Forum Infect Dis 2019.